{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T22:40:05Z","timestamp":1730068805749,"version":"3.28.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.euros.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:02:21Z","timestamp":1727182941000},"page":"89-99","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protocol for a Series of Systematic Reviews and Network Meta-analyses of Randomized Controlled Trials of Medications for Patients with Overactive Bladder Symptoms"],"prefix":"10.1016","volume":"69","author":[{"given":"Henk","family":"van der Worp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie K.","family":"Puerto Nino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco H.","family":"Blanker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnav","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neera","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostiantyn","family":"Bolsunovskyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard H.","family":"te Brummelstroete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovita L.","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rufus","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Elterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Eryuzlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramila","family":"Gaudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Gutschon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas L.","family":"Griebling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna K.","family":"Hallamies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katriina","family":"Heikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zain","family":"Izhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomas P.","family":"Kilpel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saqib","family":"Khurshid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna M.","family":"Laakkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciane C.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Loohuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Mendieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Mynttinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanieh","family":"Salehi-Pourmehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Pryalukhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikolaj","family":"Przydacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad J.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riikka","family":"T\u00e4htinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin W.M.","family":"Vernooij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe D.","family":"Violette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambertus P.W.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Brignardello-Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari A.O.","family":"Tikkinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2024.08.006_b0005","first-page":"71","article-title":"Review of the epidemiology of overactive bladder","volume":"8","author":"Eapen","year":"2016","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.euros.2024.08.006_b0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.eururo.2011.01.031","article-title":"The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study","volume":"59","author":"Vaughan","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.08.006_b0015","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/nau.23513","article-title":"The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States","volume":"37","author":"Durden","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euros.2024.08.006_b0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1464-410X.2008.08036.x","article-title":"The economic impact of overactive bladder syndrome in six Western countries","volume":"103","author":"Irwin","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2024.08.006_b0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/03007995.2020.1760806","article-title":"Impact of OAB symptoms on work, quality of life and treatment-seeking behavior in Brazil","volume":"36","author":"Gomes","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.euros.2024.08.006_b0030","first-page":"1","article-title":"Effects of overactive bladder on treatment-related behaviour and quality of life in an Eastern European country: findings from the LUTS POLAND Study","author":"Przydacz","year":"2021","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.euros.2024.08.006_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000195","article-title":"Is the prevalence of overactive bladder overestimated? A population-based study in Finland","volume":"2","author":"Tikkinen","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.euros.2024.08.006_b0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11884-017-0406-7","article-title":"The aging overactive bladder: a review of aging-related changes from the brain to the bladder","volume":"12","author":"Suskind","year":"2017","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"10.1016\/j.euros.2024.08.006_b0045","series-title":"Female genitourinary and pelvic floor reconstruction","article-title":"Behavioral modification and conservative management of overactive bladder and underactive bladder disorders","author":"Bourcier","year":"2022"},{"key":"10.1016\/j.euros.2024.08.006_b0050","article-title":"Lifestyle interventions for the treatment of urinary incontinence in adults","volume":"2015","author":"Imamura","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"year":"2024","series-title":"EAU guidelines on management of non-neurogenic female lower urinary tract symptoms","author":"Harding","key":"10.1016\/j.euros.2024.08.006_b0055"},{"year":"2024","series-title":"EAU Guidelines on non-neurogenic male lower urinary tract symptoms (LUTS)","author":"Cornu","key":"10.1016\/j.euros.2024.08.006_b0060"},{"key":"10.1016\/j.euros.2024.08.006_b0065","doi-asserted-by":"crossref","unstructured":"National Institute for Health and Care Excellence. Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline NG123. London, UK: NICE; 2019. https:\/\/www.nice.org.uk\/guidance\/ng123.","DOI":"10.1111\/bju.14763"},{"key":"10.1016\/j.euros.2024.08.006_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JU.0000000000003985","article-title":"The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder","volume":"212","author":"Cameron","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.08.006_b0075","unstructured":"National Institute for Health and Care Excellence. Lower urinary tract symptoms in men: management. NICE guideline CG97. London, UK: NICE; 2015 https:\/\/www.nice.org.uk\/guidance\/cg97."},{"key":"10.1016\/j.euros.2024.08.006_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.euros.2024.08.006_b0085","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","article-title":"A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment","volume":"75","author":"Peyronnet","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.08.006_b0090","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.eururo.2014.01.019","article-title":"What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women","volume":"65","author":"Agarwal","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.08.006_b0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eururo.2014.12.012","article-title":"A population-based survey of the prevalence, potential risk factors, and symptom-specific bother of lower urinary tract symptoms in adult Chinese women","volume":"68","author":"Zhang","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.08.006_b0100","doi-asserted-by":"crossref","first-page":"e0193959","DOI":"10.1371\/journal.pone.0193959","article-title":"A hierarchical anatomical classification schema for prediction of phenotypic side effects","volume":"13","author":"Wadhwa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.euros.2024.08.006_b0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/nau.22671","article-title":"Measurement of post-void residual urine","volume":"35","author":"Asimakopoulos","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euros.2024.08.006_b0110","unstructured":"DistillerSR Inc. DistillerSR version 2.35. https:\/\/www.distillersr.com\/2023."},{"key":"10.1016\/j.euros.2024.08.006_b0115","unstructured":"CLARITY Group at McMaster University. Tool to assess risk of bias in randomized controlled trials. https:\/\/www.distillersr.com\/resources\/methodological-resources\/tool-to-assess-risk-of-bias-in-randomized-controlled-trials-distillersr."},{"key":"10.1016\/j.euros.2024.08.006_b0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.euros.2024.08.006_b0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13643-023-02217-1","article-title":"Ten circumstances and solutions for finding the sample mean and standard deviation for meta-analysis","volume":"12","author":"Chi","year":"2023","journal-title":"Syst Rev"},{"key":"10.1016\/j.euros.2024.08.006_b0130","unstructured":"Higgins JPT, Deeks JJ, editors. Data extraction for continuous outcomes. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0. London, UK: Cochrane Collaboration; 2011. Chapter 7.7.3."},{"key":"10.1016\/j.euros.2024.08.006_b0135","unstructured":"Higgins JPT, Deeks JJ, Altman DA, editors. Missing data. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0. London, UK: Cochrane Collaboration; 2011. Chapter 16.1."},{"key":"10.1016\/j.euros.2024.08.006_b0140","doi-asserted-by":"crossref","unstructured":"Sadeghirad B, Foroutan F, Zoratti MJ, G, et al. Theory and practice of Bayesian and frequentist frameworks for network meta-analysis. BMJ Evid Based Med 2023;28:204\u20139. https:\/\/doi.org\/10.1136\/bmjebm-2022-111928.","DOI":"10.1136\/bmjebm-2022-111928"},{"key":"10.1016\/j.euros.2024.08.006_b0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.euf.2023.10.018","article-title":"How to read a network meta-analysis","volume":"9","author":"Puerto Nino","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euros.2024.08.006_b0150","doi-asserted-by":"crossref","first-page":"e074495","DOI":"10.1136\/bmj-2022-074495","article-title":"A guide and pragmatic considerations for applying GRADE to network meta-analysis","volume":"381","author":"Izcovich","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2024.08.006_b0155","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework","volume":"371","author":"Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"year":"2021","series-title":"R: a language and environment for statistical computing","author":"R Core Team","key":"10.1016\/j.euros.2024.08.006_b0160"},{"key":"10.1016\/j.euros.2024.08.006_b0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2024.08.006_b0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jclinepi.2018.08.022","article-title":"GRADE approach to rate the certainty from a network meta-analysis: avoiding spurious judgments of imprecision in sparse networks","volume":"105","author":"Brignardello-Petersen","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2024.08.006_b0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/SPV.0000000000000531","article-title":"Associations between risk factors and overactive bladder: a meta-analysis","volume":"25","author":"Zhu","year":"2019","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"10.1016\/j.euros.2024.08.006_b0180","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5468\/ogs.2018.61.3.404","article-title":"Risk factors and factors affecting the severity of overactive bladder symptoms in Korean women who use public health centers","volume":"61","author":"Chae","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.euros.2024.08.006_b0185","doi-asserted-by":"crossref","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.euros.2024.08.006_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2024.08.006_b0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2024.08.006_b0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jclinepi.2021.07.011","article-title":"GRADE guidelines 33: Addressing imprecision in a network meta-analysis","volume":"139","author":"Brignardello-Petersen","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euros.2024.08.006_b0205","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s12325-021-01972-8","article-title":"Interpretation of the meaningfulness of symptom reduction with vibegron in patients with overactive bladder: analyses from EMPOWUR","volume":"39","author":"Frankel","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.euros.2024.08.006_b0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13643-017-0473-z","article-title":"Approaches to interpreting and choosing the best treatments in network meta-analyses","volume":"6","author":"Mbuagbaw","year":"2017","journal-title":"Syst Rev"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832400630X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832400630X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T22:03:00Z","timestamp":1730066580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266616832400630X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"alternative-id":["S266616832400630X"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2024.08.006","relation":{},"ISSN":["2666-1683"],"issn-type":[{"type":"print","value":"2666-1683"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for a Series of Systematic Reviews and Network Meta-analyses of Randomized Controlled Trials of Medications for Patients with Overactive Bladder Symptoms","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}